How to Choose the Right Microbial Sequencing Service for Your Project

Figure 1: Seven-factor framework for evaluating microbial sequencing service providers.

You have a project. You know whether you need 16S amplicon sequencing, shotgun metagenomics, or long-read assembly. What you might not know is how to pick the right service provider among the dozens of commercial and academic sequencing facilities that list microbial genomics on their menu. That gap — between knowing the method and finding the lab — is where projects slow down, budgets drift, and data packages disappoint.

This guide walks through the evaluation criteria, questions, and warning signs that separate a smooth outsourcing experience from a corrective one. It assumes you have already settled on a sequencing approach. If you are still deciding between amplicon and shotgun methods, start with the companion guide to choosing microbial sequencing methods before returning here.

When Outsourcing Beats Building

Not every lab should run its own sequencing. The calculus depends less on the sequencer price tag and more on three softer variables: expertise depth, volume predictability, and opportunity cost.

In-house sequencing makes sense when sample volume is high and consistent, the required protocols are stable, and your team already has a bioinformatics pipeline that covers the deliverables your collaborators expect. Even then, maintaining a sequencer means managing reagent inventory, flow cell scheduling, and a service contract that typically runs five figures annually.

Outsourcing shifts those burdens to a provider whose entire business is running samples efficiently. For microbial projects, providers often operate platforms — PacBio Revio, ONT PromethION, Illumina NovaSeq X — that individual labs rarely purchase outright. They also maintain version-controlled protocols optimized across thousands of samples, which matters because library preparation method accounts for roughly 59% of observed community variation in metagenomic studies.

If your annual sample count does not keep a sequencer running at least one flow cell per week, outsourcing usually costs less per sample once labor, maintenance, and underutilization are included.

What a Good Provider Looks Like

A competent microbial sequencing provider demonstrates depth in four areas that general NGS facilities often treat as afterthoughts.

Sample-type experience. Microbial samples span stool, soil, tissue biopsies, swabs, water filters, low-biomass clinical specimens, and FFPE blocks. Each imposes different extraction challenges. A provider who only handles clean, high-yield samples may struggle with inhibitor-rich soil or degraded FFPE. Ask whether the team has processed samples similar to yours and whether the extraction protocol accounts for Gram-positive lysis and host DNA removal. For a broader look at how sample type and study design affect microbiome data quality, see this discussion of global cohort diversity in microbiome research.

Contamination awareness. Microbial workflows are exquisitely sensitive to reagent and environmental contamination — the well-documented "kitome" problem. A credible provider includes negative controls (extraction blanks, library blanks) in every batch, reports their results alongside sample data, and maintains contamination metrics across runs. Without this, low-biomass samples become uninterpretable.

Platform transparency. The provider should name the sequencer model, flow cell type, and chemistry version, not just the brand. An Illumina run on a MiSeq v2 kit is not equivalent to one on a NovaSeq X. For long-read projects, the basecaller version and accuracy mode (e.g., ONT super-accuracy vs. fast) change both yield and quality.

Bioinformatics depth. For microbial genomics, standard delivery should go beyond FASTQ files. Taxonomic classification, functional annotation, and assembly or amplicon sequence variant (ASV) tables are baseline expectations — not premium add-ons. The provider should disclose which reference databases and software versions are used, since database choice significantly affects taxonomic assignment accuracy and cross-study comparability.

A microbial diversity analysis service that bundles extraction, library preparation, sequencing, and bioinformatics into a single workflow reduces handoff friction and accountability gaps.

Questions to Ask Before You Sign

Before requesting a formal quote, freeze these scope parameters so proposals are comparable:

• Target method: 16S (which variable region?), ITS, shotgun metagenomics, metatranscriptomics, or whole-genome sequencing
• Number of samples, including any pilot batch
• Sample type and expected input quantity range
• Required sequencing depth per sample (reads or gigabases)
• Preferred library preparation approach
• Bioinformatics deliverables: standard pipeline or custom analyses

With these defined, a structured set of questions separates attentive partners from transactional ones.

On quality and reproducibility:

• Can you share a de-identified QC summary for a project similar in sample type and method to ours?
• What is the re-run policy for failed samples — re-extraction, re-sequencing, or both — and at whose cost?
• Are library preparation and analysis workflows version-controlled with a change log?

On contamination:

• How many negative controls run per batch, and are their results included in the standard QC report?
• What contamination thresholds trigger a batch re-run?

On bioinformatics:

• Which taxonomic classifier and reference database version do you use?
• For shotgun metagenomics, do you deliver metagenome-assembled genomes and, if so, with what completeness and contamination estimates?

A provider who answers these questions with specifics — not reassurances — signals operational maturity. For projects that need deeper functional interpretation, pairing sequencing with a dedicated microbial bioinformatics analysis service ensures that the computational work matches the experimental design.

The Data Package You Should Expect

Too many projects stall at data handoff because the deliverable list was ambiguous. A clear specification prevents the "I thought this was included" conversation. The table below maps each deliverable to its purpose and acceptance criterion.

For whole-genome projects, add assembly statistics (N50, total length, checkM completeness and contamination estimates) to this list. A microbial whole-genome sequencing service should deliver genome assemblies alongside raw reads — not as a separate line item.

If any deliverable is optional or conditional, the contract or statement of work should state the trigger explicitly. Ambiguity on deliverables is the most common source of post-project friction in outsourced sequencing.

Figure 2: Decision flowchart for choosing between in-house and outsourced microbial sequencing.

Turnaround, Cost, and What Shifts Them

Turnaround time (TAT) and cost are tightly coupled. Understanding what drives both helps you negotiate a scope that fits without hidden compromises.

Turnaround drivers. TAT should be measured from your sample's arrival at the facility, not from the sequencer start date. Providers who quote from "run start" may be hiding a queue. Confirm whether TAT stops during QC holds and what triggers a reset. Realistic TAT for standard 16S amplicon is two to four weeks from sample receipt. Shotgun metagenomics adds one to two weeks for library preparation and bioinformatics. These are general benchmarks — actual turnaround time depends on project scope, sample type, and current queue. For a specific TAT estimate based on your project, please contact us directly.

Cost drivers. The per-sample sequencing cost is only part of the total. Extraction, library prep, bioinformatics, data storage, and project management each add line items:

• Sample count and sequencing depth per sample — the two largest levers
• Sample complexity — inhibitor-rich or degraded samples may need rescue protocols
• Bioinformatics scope — custom analyses, MAG generation, or multi-omics integration raise cost
• Expedited TAT — a rush surcharge of 25–50% is not unusual
• Host depletion for shotgun metagenomics of host-associated samples
• Re-sequencing policy — quotes that appear cheaper often exclude failed-sample re-runs

When comparing quotes, build a total-cost comparison with a contingency for re-runs. The cheapest quote rarely stays cheapest through project close.

Figure 3: Typical project journey from inquiry to data delivery, with milestone-based TAT tracking.

Red Flags That Cost You Later

A few warning signs during the evaluation stage predict downstream problems with high reliability.

No prior-run data. A provider unwilling or unable to share a de-identified QC report from a similar project is either inexperienced with your sample type or inconsistent in quality.

Undefined re-run policy. If the contract does not say what happens when a sample fails QC — who decides, who pays, how many attempts are permitted — assume the answer will be "you pay."

Generic bioinformatics. Providers who deliver FASTQ files and nothing else for microbial projects shift the entire analytical burden back to you. Even if you have in-house bioinformatics capacity, receiving taxonomy tables and QC summaries provides an independent quality check.

No contamination reporting. If negative control data is not part of the standard delivery for a microbial project, you cannot distinguish biological signal from workflow noise. This is non-negotiable for low-biomass sample types such as skin swabs, respiratory samples, or tissue biopsies.

Unclear communication cadence. A provider without a named project manager and a defined update schedule — even a brief weekly email — leaves you blind between sample shipment and data delivery.

These red flags do not mean a provider is incompetent. They mean the provider is not set up for the kind of structured, auditable microbial genomics work that produces reproducible results. For a practical view of how reproducible data pipelines support biomarker studies, see this framework for moving microbiome biomarkers from discovery to validation.

Writing an Inquiry That Gets Answered

A strong initial inquiry shortens the back-and-forth by giving the provider everything needed to return a meaningful quote in one round. The most effective inquiries include:

• A one-paragraph description of the biological question and study design
• Sample type, species, estimated number of samples, and expected DNA/RNA concentration range
• The sequencing method and approximate depth per sample
• Bioinformatics deliverables needed
• Target timeline and any hard deadlines (grant reporting, manuscript submission)
• Whether a pilot or feasibility phase is planned before full production

Avoid vague requests like "please quote for microbiome sequencing of 100 samples." Without method, depth, and deliverable expectations, every provider will interpret the scope differently, and the resulting quotes will not be comparable.

For researchers working within a specific budget ceiling, stating the budget range upfront allows the provider to propose a scope that maximizes data value within that constraint. Most project teams at established sequencing facilities can suggest trade-offs — fewer samples at higher depth, or more samples with shallow shotgun instead of deep metagenomics — once they know the real constraint.

FAQ

How do I know if I need single-end or paired-end sequencing?

For 16S amplicon sequencing, paired-end reads that fully overlap (typically 2 × 250 bp for the V3–V4 region) are the standard, as they allow error correction in the overlap region and produce higher-quality ASVs. For shotgun metagenomics, paired-end 2 × 150 bp provides sufficient length for taxonomic classification and gene-level functional annotation. Single-end sequencing is sometimes used for shallow shotgun or targeted amplicon panels where cost reduction is the primary goal, but it sacrifices read-level quality control and should be chosen deliberately rather than by default.

What is a reasonable sequencing depth for 16S amplicon versus shotgun metagenomics?

For 16S amplicon sequencing of complex microbial communities such as gut or soil, 30,000 to 50,000 reads per sample typically captures the majority of diversity, though low-abundance taxa may require deeper sequencing. The Earth Microbiome Project standard rarefies to as few as 5,000 reads per sample for broad community comparisons. For shotgun metagenomics, 10 to 30 million read pairs per sample is common for human stool, with higher depth — 50 million or more — needed for samples with substantial host DNA content or for recovering rare genome bins.

How many negative controls should a provider include, and what should I see in the results?

At minimum, one extraction blank and one library preparation blank should be included per batch. For low-biomass samples, additional blanks — including swab or collection-device blanks if applicable — strengthen the interpretation. In the results, negative controls should yield substantially fewer reads than the lowest-concentration sample. If a negative control produces a complex community profile, the batch warrants closer scrutiny. Providers should report negative control results alongside sample data, not in a separate appendix where they are easy to overlook.

Can I split my samples across multiple sequencing providers?

Technically yes, but doing so introduces a batch effect that can be as large as the biological signal you are trying to measure. DNA extraction method, library preparation kit, sequencer model, and bioinformatics pipeline each contribute systematic differences. If splitting is unavoidable — for example, when a large multi-year study spans different funding cycles — use a common positive control or mock community sample across all batches and plan for batch-correction analysis from the start.

What should I do if the data does not meet the agreed QC thresholds?

The provider's re-run or rescue policy, which should be documented in the statement of work before the project begins, governs this situation. If the shortfall is clearly on the provider's side — insufficient read depth due to a failed sequencing run, for example — re-sequencing at the provider's cost is standard. If the issue originates with sample quality that was disclosed and accepted during intake, the resolution path should already be defined. Without a documented policy, you are negotiating from a weak position after the data arrives.

Is it better to choose a provider that specializes only in microbial work, or a large general NGS provider?

Microbial-specialist providers tend to offer deeper sample-type expertise, more relevant contamination controls, and bioinformatics pipelines tuned for microbiome data — all of which reduce the effort required on your side. Large general NGS providers, by contrast, may offer lower per-sample costs through economies of scale and greater platform diversity, but their standard workflows are often optimized for human or model-organism genomics and may require adaptation for microbial projects. The right choice depends on how much in-house microbial expertise your team already has. If you can evaluate and customize workflows yourself, a general provider may work. If you want the provider to guide sample preparation decisions and deliver analysis-ready microbial data, a specialist saves time.

Related CD Genomics Services

• Microbiome Sequencing Services — End-to-end sequencing across amplicon, shotgun, and long-read platforms for microbial research.
• Metagenomics Analysis Platform — Shotgun metagenomics with functional annotation, taxonomic profiling, and MAG recovery.

References

1. Gulyás G, Kakuk B, Dörmő Á, et al. Cross-comparison of gut metagenomic profiling strategies. Communications Biology. 2024;7:1445. doi:10.1038/s42003-024-07158-6
2. Regueira-Iglesias A, Balsa-Castro C, Blanco-Pintos T, Tomás I. Critical review of 16S rRNA gene sequencing workflow in microbiome studies: from primer selection to advanced data analysis. Molecular Oral Microbiology. 2023;38(5):347-399. doi:10.1111/omi.12434
3. Hiergeist A, Ruelle J, Emler S, Gessner A. Reliability of species detection in 16S microbiome analysis: comparison of five widely used pipelines and recommendations for a more standardized approach. PLOS ONE. 2023;18(2):e0280870. doi:10.1371/journal.pone.0280870
4. De Wolfe TJ, Wright ES. Multi-factorial examination of amplicon sequencing workflows from sample preparation to bioinformatic analysis. BMC Microbiology. 2023;23(1):107. doi:10.1186/s12866-023-02851-8
5. Kim C, Pongpanich M, Porntaveetus T. Unraveling metagenomics through long-read sequencing: a comprehensive review. Journal of Translational Medicine. 2024;22(1):111. doi:10.1186/s12967-024-04917-1
6. Mirzayi C, Renson A, Zohra F, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nature Medicine. 2021;27(11):1885-1892. doi:10.1038/s41591-021-01552-x

For Research Use Only. Not for use in diagnostic or therapeutic procedures.